Jessay Gopuran Devassy

Jessay Gopuran Devassy

Auto-generated profile, based on publicly available information

Jessay Gopuran Devassy

Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Canada; and Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, Winnipeg, Canada

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Advances in Nutrition
Verified
Journal Article
Open access
PDF file
MGMelissa Gabbs
Melissa Gabbs
SLShan Leng
Shan Leng
JDJessay G Devassy
Jessay G Devassy
MMMd Monirujjaman
Md Monirujjaman
HAHM Aukema
HM Aukema
Oxylipins formed from polyunsaturated fatty acids (PUFAs) are the main mediators of PUFA effects in the body. They are formed via cyclooxygenase, lip

12 February 2015 in Nutrition Reviews
Verified
Journal Article
Open access
PDF file
JDJessay G. Devassy
Jessay G. Devassy
INIfeanyi D. Nwachukwu
Ifeanyi D. Nwachukwu
PJPeter J.H. Jones
Peter J.H. Jones
Curcumin is a highly pleiotropic molecule found in the rhizomes of Curcuma longa (turmeric). It is responsible for the yellow color of turmeric and has been shown to inhibit the proliferation of cancer cells and to be of use in preventing or treating a number of diseases. Curcumin has been shown to modulate multiple cell-signaling pathways simultaneously, thereby mitigating or preventing many different types of cancers, including multiple myeloma and colorectal, pancreatic, breast, prostate, lung, head, and neck cancers, in both animal models and humans. Current therapeutic approaches using a single cancer drug for a single target can be expensive, have serious side effects, or both. Consequently, new approaches to the treatment and prevention of cancer, including the integration of curcumin as a viable treatment strategy where dysregulation of many pathways is involved, are warranted. A methodical review of the evidence was performed to evaluate the effects of curcumin in support of a health claim, as established through the regulatory framework of Health Canada, for a relationship between the consumption of curcumin and the prevention and treatment of cancer.

1 September 2016 in Advances in Nutrition
Verified
Journal Article
Closed access
PDF file
JDJessay Gopuran Devassy
Jessay Gopuran Devassy
SLShan Leng
Shan Leng
MGMelissa Gabbs
Melissa Gabbs
MMMd Monirujjaman
Md Monirujjaman
HAHM Aukema
HM Aukema
Alzheimer disease (AD) is becoming one of the most prevalent neurodegenerative conditions worldwide. Although the disease progression is becoming bet

6 December 2015 in Obesity
Verified
Journal Article
Open access
PDF file
JWJennifer L. Wojcik
Jennifer L. Wojcik
JDJessay G. Devassy
Jessay G. Devassy
YWYinghong Wu
Yinghong Wu
Peter ZahradkaPeter Zahradka
Peter Zahradka
CTCarla Taylor
Carla Taylor
HAHM Aukema
HM Aukema
Objective: High‐protein diets are being promoted to reduce insulin resistance and hepatic steatosis in metabolic syndrome. Therefore, the effect of protein source in high‐protein diets on reducing insulin resistance and hepatic steatosis was examined.Methods: Fa/fa Zucker rats were provided normal‐protein (15% of energy) casein, high‐protein (35% of energy) casein, high‐protein soy, or high‐protein mixed diets with animal and plant proteins.Results: The high‐protein mixed diet reduced area under the curve for insulin during glucose tolerance testing, fasting serum insulin and free fatty acid concentrations, homeostatic model assessment index, insulin to glucose ratio, and pancreatic islet cell area. The high‐protein mixed and the high‐protein soy diets reduced hepatic lipid concentrations, liver to body weight ratio, and hepatic steatosis rating. These improvements were observed despite no differences in body weight, feed intake, or adiposity among high‐protein diet groups. The high‐protein casein diet had minimal benefits.Conclusions: A high‐protein mixed diet was the most effective for modulating reductions in insulin resistance and hepatic steatosis independent of weight loss, indicating that the source of protein within a high‐protein diet is critical for the management of these metabolic syndrome parameters.

1 January 2015 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
NINaser H.M. Ibrahim
Naser H.M. Ibrahim
MGMelanie Gregoire
Melanie Gregoire
JDJessay G. Devassy
Jessay G. Devassy
YWYinhong Wu
Yinhong Wu
DYDaisuke Yoshihara
Daisuke Yoshihara
HAHM Aukema
HM Aukema

30 October 2013 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
NINaser H. M. Ibrahim
Naser H. M. Ibrahim
YJYong Jia
Yong Jia
JDJessay G. Devassy
Jessay G. Devassy
TYTamio Yamaguchi
Tamio Yamaguchi
HAHM Aukema
HM Aukema